Quote:
Originally Posted by Scroopy Noopers
Are you arguing that Pfizer’s CEO sold his stock due to the fact Moderna’s vaccine is easier to distribute? Or are you just ignoring what I’m responding to?
|
Sorry I still don't quite see it the way I think you do.
This stock sale plan was renewed on August 19, the day before they released the results of the initial trial. All along the Pfizer CEO had been talking about a November release of the extended trial results. And in that stock sale plan approved in August, it had him selling 60% of his stock in early November. And in August did they know they were neck and neck with Moderna on timing of releasing results? I'm sure they did.
It's why these stock sale plans are not the great defenders of transparency that some make them out to be. Frankly, there might be more transparency if executives had control over the sale since any monkey business would be easier to identify.
I don't see any conspiracy here. Too many moving parts. But did the CEO just magically fall into this through good fortune? Nope. There was no way that stock sale plan should have been renewed as it was in August, a day before the initial press release with him selling 60% of his stock at around the expected time of the next press release.
The Moderna executives were under the same scrutiny for their initial press release and subsequent stock sales.